MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New PET/MR Imaging Technique Could be a Game Changer for Treatment of Crohn's Disease

By MedImaging International staff writers
Posted on 12 Apr 2023
Print article
Image: New imaging technique could result in more effective therapy for patients suffering from Crohn`s disease (Photo courtesy of Freepik)
Image: New imaging technique could result in more effective therapy for patients suffering from Crohn`s disease (Photo courtesy of Freepik)

Crohn's disease, a chronic inflammatory intestinal disorder, often results in painful bowel constrictions known as intestinal strictures. These strictures commonly cause cramping pain and digestive issues in patients with Crohn's disease and typically require treatment. While drug therapies effectively treat purely inflammatory strictures, surgical intervention is needed for fibrotic narrowing, which involves irreversible tissue changes. However, varying degrees of inflammation and fibrosis often coexist, and until recently, there has been a lack of methods to accurately characterize these complications for targeted treatment. Currently, no imaging procedure allows for therapy-relevant differentiation between intestinal wall inflammation and fibrosis. Now, a new imaging technique may enhance the treatment of intestinal strictures.

Interdisciplinary research at the Medical University of Vienna (Vienna, Austria) has employed a novel nuclear medicine tracer for the first time in pursuit of more accurate imaging methods. This FAPI tracer specifically binds to the fibroblast activating protein (FAP) of connective tissue cells that cause fibrosis in the affected intestinal wall. By using the new tracer, PET-MRI diagnostic procedures have demonstrated a strong correlation between molecular imaging and the pathological extent of fibrosis. This technique even allows for differentiation between moderate and severe intestinal wall fibrosis, which is essential for making therapy decisions.

"In future, the molecular imaging we have developed could be used to identify those patients who would benefit from surgical intervention at an early stage, thereby sparing them the need for less effective drug therapy for fibroid-stenosis," said co-study leader Michael Bergmann from the Department of Visceral Surgery at MedUni Vienna's Department of General Surgery.

Related Links:
MedUni Vienna 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
1.5T MRI System
uMR 670
Ultrasound System
Acclarix AX9
Computed Tomography (CT) Scanner
Aquilion Serve SP

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more